Bioelectronics Corp (BIEL)

[srinsocal]

"CITE THE JOURNAL ARTICLE." 'Pain Research and Management'

A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel
OTC Neuromodulation Therapy
Received 25 June 2019; Accepted 7 September 2019; Published 30 September 2019

"Results. Seven days after initial treatment, the average pain was reduced to 2.9, a 65% pain reduction for the study subjects. At the 6-month measurement, the average pain was 3.3, a 60% pain reduction from baseline."

"A decline in treatment effectiveness is commonly associated
with long-term use of pharmacological treatments, for example, with NSAIDS [26] and opioids, owing to tolerance [27].The goal of this prospective study is to assess the durability of treatment effectiveness for the PSWT medical device over a 6-month period".

Table 3: Analgesic medications used by the study sample.
Analgesics Fraction of users (%)
NSAIDS (e.g., ibuprofen) 43
Paracetamol 61
Weak opioids (e.g., codeine) 25
Strong opioids (e.g., hydrocodone) 11
Tramadol or equivalent 8
Pregabalin (e.g., Lyrica) 8
Amitriptyline 17
Topical opioid (e.g., morphine) 8
Topical NSAIDS (e.g., Voltarol) 21
Gabapentin 2
Other 4
No analgesics 5


"Pain Research and Management is a peer-reviewed, open access journal which publishes original research articles and review articles involving laboratory, including neuroimaging and neurophysiology, and clinical findings in the field of pain research. The journal also looks into the prevention, treatment and management of pain. The journal aims to increase the current knowledge about the pain mechanisms and encouraging the development of effective and safety treatments for pain. "

https://downloads.hindawi.com/journals/prm/2019/3154194.pdf